Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
160.9 USD | +0.83% | -4.44% | +3.53% |
02:52pm | Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196 | MT |
02:31pm | Barclays Adjusts Price Target on AbbVie to $187 From $195 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.53% | 283B | |
+25.68% | 661B | |
+27.00% | 566B | |
-6.21% | 352B | |
+20.49% | 332B | |
+14.36% | 231B | |
+5.10% | 200B | |
-9.00% | 195B | |
-5.06% | 145B | |
-10.39% | 144B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Acrux Files US FDA Application for Generic Topical Medication; Shares Jump 7%